Form 4: Caribou Biosciences Executive Khan Ruhi Ahmad Reports Stock Transactions

Ruhi Ahmad Khan, Chief Business Officer of Caribou Biosciences, reports acquisition of restricted stock units and sale of common stock to cover tax obligations.

Summary

• Ruhi Ahmad Khan, Chief Business Officer of Caribou Biosciences, filed a Form 4 detailing changes in beneficial ownership.
• On February 20, 2025, Khan acquired 37,500 restricted stock units (RSUs) that vest in four equal annual installments beginning February 20, 2026.
• These RSUs will be settled in stock within 30 days after each vesting date.
• On February 21, 2025, Khan sold 3,564 shares of common stock at a weighted average price of $1.35 per share.
• This sale was to cover tax withholding obligations related to the vesting of previously granted RSUs and was executed under a Rule 10b5-1 trading plan.
• Khan also acquired options to purchase 170,000 shares of common stock at an exercise price of $1.41, vesting over 4 years from February 20, 2026, to February 19, 2035.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions are routine and expected as part of executive compensation and tax management.

Positives

• The acquisition of RSUs and options indicates continued alignment of the executive's interests with the company's long-term performance.

Negatives

• The sale of shares, although for tax obligations, could be perceived negatively by some investors if not understood in context.

Risks

• The vesting of RSUs and options is contingent upon the reporting person's continued service to the Issuer, creating a retention risk.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of the RSUs and options suggest a multi-year commitment from the executive.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and alignment with shareholder interests.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but the overall impact is likely to be minimal.

Key Dates

Keywords

Form 4, Caribou Biosciences, CRBU, Khan Ruhi Ahmad, Chief Business Officer, Restricted Stock Units, RSUs, Stock Options, Beneficial Ownership, Rule 10b5-1